Armada B2140-080Recalls & reported problems
Abbott Vascular Inc. · Armada 35 PTA Catheter 14 mm x 80 mm x 135 cm / Over-The-Wire · Class 2
All models of Armada (213)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648155611), received between Aug 17, 2022 and Sep 24, 2022 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Material Rupture” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Material Rupture2
- Improper or Incorrect Procedure or Method1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 24, 2022Material Rupture; Improper or Incorrect Procedure or Method; Material Rupture; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MODERATELY CALCIFIED, 70% STENOSED LESION IN THE LEFT SUPERIOR FEMORAL ARTERY (SFA). A 14X80MM ARMADA 35 BALLOON DILATATION CATHETER (BDC) WAS ADVANCED TO THE TARGET LESION AND INFLATED ONE TIME TO 8 ATMOSPHERES (ATM) WHEN THE BALLOON RUPTURED. THE BDC WAS REMOVED, AND A NEW BALLOON WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15477208 ↗MalfunctionAug 17, 2022Material Rupture; Material Rupture
USER FACILITY MEDWATCH REPORT (4500440000-2022-8030) RECEIVED STATING: THE SURGEON PERFORMED ANOTHER INTRAVASCULAR ULTRASOUND, WHICH SHOWED SOME EVIDENCE OF INCOMPLETE EXPANSION AT THE MOST PROXIMAL ASPECT OF THE ABRE STENT AT THE INFERIOR VENA CAVA NOTCH AND SOME LEVEL OF LUMINAL LOSS. TO ADDRESS THIS PROBLEM, THE SURGEON THEN ADVANCED WITH THE 12 ARMADA BALLOONS FROM BOTH FEMORAL VEIN ACCESS AND BALLOONED THE MOST PROXIMAL ASPECT USING THE KISSING BALLOON TECHNIQUE TO GAIN A GOOD WALL APPOSITION AND EXPANSION OF THE ABRE STENT AT ITS PROXIMAL EXTENT. WHAT WAS THE ORIGINAL INTENDED PROCEDURE? : BILATERAL ILIOCAVAL RECONSTRUCTION. WHAT PROBLEM DID THE USER HAVE (CHECK ALL THAT APPLY) : DEVICE FAILED (E.G. BROKE, COULDN'T GET IT WORK OR STOPPED WORKING). NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15244355 ↗
Other CATHETER, PERCUTANEOUS devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page